Noel Smith, PhD, Head of Immunology, Lonza
Noel completed his PhD and subsequent post-doctoral studies at the University of Cambridge in the field of metabolic disease. Noel joined Lonza in 2009 and was involved in the setup of the human primary cell-based assay platform. He now Heads the Immunology group which develops assays to screen products for immunogenicity and immunotoxicity risk.
